Skip to content

Homeopathic medicines in dyspepsia

Double-blind, randomized, placebo-controlled trial of individualized homeopathic medicines in functional dyspepsia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/036044
Enrollment
140
Registered
2021-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: Individualised homeopathic medicine: Dose-Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies, as decided appropriate to the case or condit
dosage and repetition depending upon the individual requirement of the cases ?. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth withi
dosage and repetition depending upon the individual requirement of the cases

Sponsors

Gurudev Choubey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Functional dyspepsia (ICD-10-CM Diagnosis Code K30) as per the Rome IV criteria 2.. “Patients already undergoing regular therapy for dyspeptic ailments, provided the medications are stopped completely at least 2 weeks prior study entry ? 3.. “Literate patients; ability to read Bengali and/or English ? 4. Providing written informed consent

Exclusion criteria

Exclusion criteria: 1. Recent significant GI surgery within last 6 months 2. Patients who are too sick for consultation 3. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life 4. Pregnancy, puerperium and lactation 5. Substance abuse and/or dependence 6. Self-reported immune-compromised state, and 7. Undergoing homeopathic treatment for any chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
Leeds Dyspepsia Questionnaire - Short Form (LDQ-SF)Timepoint: Baseline, every month, up to 3 months

Secondary

MeasureTime frame
Frequency of use of standard conventional drugs for functional dyspepsia during study period of 3 monthsTimepoint: Baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactDr Charanjeet singh

SriGanganagar Homepathic medical college and Research centre

sgnhh@yahoo.com9414225433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026